MYP_056850
Unnamed
Anticancer
Immunology
▸
Immunomodulation
▸
Immunogenic
Standard
9 amino acids
C51H78N12O13S2
Standard
FLDRFLSCM
1131.37 Da
5.83
-0.25
-0.47
-0.0276
0.98
0.64
0.20
72.96
86.67
0.2222
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
415.55
-1.73
16.0
15.0
36.0
78.0
2.0
8.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0237199
VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
acute myeloid leukemia (AML); HLA-A*02:01
0.03252 μM
Predicted HLA-I binding
RECORD: Rec_0339580
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Immunogenic
acute myeloid leukemia (AML); HLA-A*02:01
Intracellular cytokine staining (ICS)
RECORD: Rec_0407860
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Immunogenic
acute myeloid leukemia (AML); HLA-A*02:01
51Cr release